Papers
3
Total Citations
59
H-Index
2
About
F. Collamati is a leading researcher in the field of radioguided surgery, with a specific focus on the development of innovative intraoperative detection technologies for prostate cancer. Their primary contributions center on the design and validation of a novel DROP-IN beta probe, a device engineered for seamless integration with robotic surgical systems. This work represents a significant paradigm shift, moving from traditional gamma-based detection to the use of beta-emitting PET isotopes, such as 68Ga-PSMA, to achieve higher sensitivity and precision. Collamati’s landmark 2020 study, cited over 40 times, provided the first ex vivo technology evaluation of this probe using prostate cancer specimens, demonstrating its potential to improve the accuracy of tumor resection. This foundational work was followed by a groundbreaking first-in-human validation in 2024, which established the optimal signal-to-background discrimination algorithm for clinical use. By bridging the gap between preoperative PET/CT imaging and intraoperative guidance, Collamati’s research is paving the way for more effective, minimally invasive cancer surgeries, directly impacting patient outcomes in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3